Expression, purification and characterization of the human membrane transporter protein OATP2B1 from Sf9 insect cells

OATP2B1 is an important member of the organic anion transporting polypeptides (OATP) family and is implicated in the intestinal and hepatic disposition of endo- and xenobiotics. The purpose of this work was to produce a highly purified protein for use as a reference standard for quantification of OATP2B1 in human tissue and in vitro assay systems. Here, we report the successful expression, purification and characterization of OATP2B1 in a heterologous expression system. Protein expressed by the Sf9-baculovirus expression system is functionally active as demonstrated by saturable uptake kinetics with a K(m) of 5.9+/-0.76 microM for estrone-3-sulfate. OATP2B1 was extracted from Sf9-membranes with ABS-14-4 detergent and purified using a one-step FLAG-tag purification method. Yield of OATP2B1 from Sf9 cells was 1.1mg per liter of culture, for a final recovery of 1.8%. SDS-PAGE resolution and Western blot of purified protein displayed multiple banding of OATP2B1-specific protein, which was thoroughly investigated to confirm homogeneity of the sample. C-terminal FLAG-tag purification and immunoblot detection, together with N-terminal sequencing, confirmed the presence of only full-length protein. Treatment with endoglycosidases had little effect on the migration pattern in SDS-PAGE, suggesting that multiple banding was not due to different glycosylation states of the protein. Amino acid analysis further confirmed the homogeneity of the protein with a calculated extinction coefficient of 80,387 cm(-1) M(-1). Physical, biochemical and functional characterization show that purified human OATP2B1 is pure, homogeneous and appropriate for use as a standard to quantitate expression of OATP2B1 in in vitro systems and tissue samples.     

Identifi cation of antibiotics that are effective 2 in eliminatingAgrobacterium tumefaciens

An assay was performed to identify the antibiotics that are most effective againstAgrobacterium tumefaciens strains EHA101 and LBA4404, and to determine if these antibiotics inhibited tobacco callus and shoot formation. We tested ten antibiotics: cefotaxime, carbenecillin, erythromycin, spectinomycin, polymixin B, chloramphenicol, methicillin, Augmentin 500, Augmentin 250, and moxalactam. The effectiveness of each antibiotic against the two strains was determined by measuring the zones of inhibition of bacterial growth in a disk-diffusion assay. The five antibiotics that generated the largest zones of inhibition for each strain were assayed to determine their effects on callus formation. Cefotaxime was the most active antibiotic tested against strain LBA4404, and moxalactam was the most effective antibiotic against EHA101. Both cefotaxime and moxalactam had little or no effect on callus development.     

Comparison of Treatment Outcomes of New Smear-Positive Pulmonary Tuberculosis Patients by HIV and Antiretroviral Status in a TB/HIV Clinic,Malawi

Background

Smear-positive pulmonary TB is the most infectious form of TB. Previous studies on the effect of HIV and antiretroviral therapy on TB treatment outcomes among these highly infectious patients demonstrated conflicting results, reducing understanding of important issues.

Methods

All adult smear-positive pulmonary TB patients diagnosed between 2008 and 2010 in Malawi’s largest public, integrated TB/HIV clinic were included in the study to assess treatment outcomes by HIV and antiretroviral therapy status using logistic regression.

Results

Of 2,361 new smear-positive pulmonary TB patients, 86% had successful treatment outcome (were cured or completed treatment), 5% died, 6% were lost to follow-up, 1% failed treatment, and 2% transferred-out. Overall HIV prevalence was 56%. After adjusting for gender, age and TB registration year, treatment success was higher among HIV-negative than HIV-positive patients (adjusted odds ratio 1.49; 95% CI: 1.14–1.94). Of 1,275 HIV-infected pulmonary TB patients, 492 (38%) received antiretroviral therapy during the study. Pulmonary TB patients on antiretroviral therapy were more likely to have successful treatment outcomes than those not on ART (adjusted odds ratio : 1.83; 95% CI: 1.29–2.60).

Conclusion

HIV co-infection was associated with poor TB treatment outcomes. Despite high HIV prevalence and the integrated TB/HIV setting, only a minority of patients started antiretroviral therapy. Intensified patient education and provider training on the benefits of antiretroviral therapy could increase antiretroviral therapy uptake and improve TB treatment success among these most infectious patients.     

Evolution of Growth Hormone in Primates: The GH Gene Clusters of the New World Monkeys Marmoset (Callithrix jacchus) and White-Fronted Capuchin (Cebus albifrons)

The GH gene cluster in marmoset, Callithrix jacchus, comprises eight GH-like genes and pseudogenes and appears to have arisen as a consequence of gene duplications occurring independently of those leading to the human GH gene cluster. We report here the complete sequence of the marmoset GH gene locus, including the intergenic regions and 5′ and 3′ flanking sequence, and a study of the multiple GH-like genes of an additional New World monkey (NWM), the white-fronted capuchin, Cebus albifrons. The marmoset sequence includes 945 nucleotides (nt) of 5′ flanking sequence and 1596 nt of 3′ flanking sequence that are “unique”; between these are eight repeat units, including the eight GH genes/pseudogenes. The breakpoints between these repeats are very similar, indicating a regular pattern of gene duplication. These breakpoints do not correspond to those found in the much less regular human GH gene cluster. This and phylogenetic analysis of the repeat units within the marmoset gene cluster strongly support the independent origin of these gene clusters, and the idea that the episode of rapid evolution that occurred during GH evolution in primates preceded the gene duplications. The marmoset GH gene cluster also differs from that of human in having fewer and more evenly distributed Alu sequences (a single pair in each repeat unit) and a “P-element” upstream of every gene/pseudogene. In human there is no P-element upstream of the gene encoding pituitary GH, and these elements have been implicated in placental expression of the other genes of the cluster. The GH gene clusters in marmoset and capuchin appear to have arisen as the consequence of a single-gene duplication event, but in capuchin there was then a remarkable expansion of the GH locus, giving at least 40 GH-like genes and pseudogenes. Thus even among NWMs the GH gene cluster is very variable. [Reviewing Editor: Nicolas Galtier]     

A novel method for targeting survey effort to identify new bat roosts using habitat suitability modelling

In the UK, four out of 18 bat species are listed on the EU Habitats Directive, including the lesser horseshoe bat (Rhinolophus hipposideros), and their population status is closely monitored by visiting known roosts. R. hipposideros predominantly form maternity roosts in buildings, but roosts are impermanent features in the landscape and their distribution changes as bats form new roosts and abandon others. Locating new roosts requires intensive surveys which are challenging and inefficient. In this study, we provide a novel model-based strategy to identify potential R. hipposideros maternity roost sites that can be used to monitor bat populations. First, we model potential maternity roost habitat using record centre data on roost locations across Wales, Great Britain. We then constrain the area identified from modelling using record centre data on locations of bats in areas with no known roosts. We used two variable selection methods and three pseudo-absence data sets (random background points, random points in buildings and target group selection of mammal records) to produce six habitat suitability models. The three pseudo-absence data sets produced different habitat suitability maps, demonstrating the influence of pseudo-absence selection on species distribution models. The six models were combined using weighted mean average to produce an ensemble model that performed better than individual models and that indicated high levels of congruence in areas predicted to have high habitat suitability for maternity roosts. Our model revealed an extensive area (6523 km²; 31% of the area of Wales) containing 18,051 buildings in suitable habitat. Using record centre data on bat activity outside commuting range from known roosts reduced the potential survey area to 133 km² (0.6% of the area of Wales) and 207 buildings. Our modelling outputs can be used to direct volunteers and bat surveyors in more targeted and efficient searches.     

In Situ Biodegradation of High Explosives in Soils: Field Demonstration

The first field pilot-scale demonstration of a technology for in situ remediation of vadose zone soils contaminated with high explosives (HEs) has been performed at the Department of Energy's Pantex Plant. The HEs of concern at the demonstration site were hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX) and the 2,4,6-trinitrotoluene (TNT) metabolite 1,3,5-trinitrobenzene (TNB). Concentrations ranged from 70 ppm, above the (prior to 1999) risk reduction clean-up criteria of 2.6 and 0.51 ppm, respectively. The shallow (<10?m depth) soils at the site could not be excavated due to the presence of buried utilities. Based on previous laboratory studies, it was found that the contaminated soils had indigenous microbial populations that could be stimulated to degrade the RDX and TNB anaerobically. A 5-spot well pattern with injection at the central well and extraction at the four outer wells (each 4.6?m from the injection well) was used to flood the target vadose zone soils with nitrogen gas with the intent of stimulating the activity of the HE degraders. The system was monitored periodically for gas composition as well as HE concentrations and microbial activity in retrievable soil samples. After 295 days of in situ treatment, the average target HE concentrations were approximately one-third lower than the initial site averages. Operation of the pilot-scale treatment system continues.     

Developmental control of the β-phaseolin gene requires positive, negative, and temporal seed-specific transcriptional regulatory elements and a negative element for stem and root expression

To identify cis-acting regulatory elements responsible for developmental control of the common bean seed storage protein β-phaseolin, a series of 5′-deletion mutants of the 782 bp upstream sequence together with the coding and 3′-regions of the β-phaseolin gene were used to transform tobacco. One major positive regulatory element (?295/?228) and a putative minimal promoter (?64/?14) were indicated by large reductions in phaseolin mRNA and protein concentrations in seeds of plants deficient for these regions. In addition, minor negative (?422/?296) and positive (?782/?423) elements also influenced the level of phaseolin mRNA expression in seeds. One temporal element (?295/?107) governed late expression of phaseolin mRNA in seeds, and possibly a second (?64/?14) regulated early expression. The ?64/?14 promoter containing two TATA boxes conferred spatially regulated gene expression, and was sufficient for a low level of expression in root and stem. Significant levels of phaseolin mRNA and protein were detected in stem cortices and secondary roots of plants lacking the ?295/?107 negative element. No significant expression in leaf tissue was detected. Results demonstrate that developmental control of β-phaseolin requires a minimal promoter, one element for the suppression of expression in root and stem tissue, three elements governing quantitative expression in seeds, and at least one temporal element controlling expression in seeds.     

Estrogenic tamoxifen derivatives: Categorization of intrinsic estrogenicity in MCF-7 cells

Triarylethylenes bearing acetic acid side chains, exemplified by 4-[1-(p-hydroxyphenyl)-2-phenyl-1-butenyl]phenoxyacetic acid (4HTA), a derivative of tamoxifen (TAM), are of current interest as estrogen mimics lacking reproductive tract effects. Affinities for estrogen receptors (ER) and effects on cell growth kinetics of a diverse series of such compounds were compared with 4HTA, TAM, and with standard estrogens 17β-estradiol (E₂) and chlorotrianisene (CTA) in MCF-7 cells. These compounds exhibited concentration dependent cell growth stimulation comparable to that of CTA but less than that of E₂. Growth stimulation of the more potent compounds was antagonized by TAM, signifying that effects were mediated via interaction with ER. At concentrations of 1 μM or higher, compounds with efficacies less than that of E₂ were weak antagonists of estradiol-stimulated growth. Both intracellular ER affinities and growth rate stimulation potencies of the triarylethylene acetic acids and the standard ER ligands varied over a range of nearly three orders of magnitude. Analysis of growth stimulatory potency as a function of ER affinity revealed dual parallel correlations: the potency/ER affinity ratios of 4HTA and four of its analogues was about 100-fold less than those of the hydroxytriarylethane and bisphenolic analogs and the three standard ER ligands. These results suggested that ER liganded with the latter substances is more ‘effective’ at nuclear effector sites than is ER liganded with 4HTA and the other acidic triarylethylenes.